Results from a large multinational clinical trial (guardian (TM) 1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy

Lentz S. R.;Misgav M.;Ozelo M.;Salek S. Z.;Veljkovic D.;Recht M.;Cerqueira M.;Tiede A.;Brand B.;Mancuso M;Seremetis S.;Lindblom A.;Martinowitz U.

2013-01-01